Brian Baranick insider trades: Exact Sciences (EXAS) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Brian reports to the SEC
Open-market buys and sales
14 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 4, 2025 | EXAS | ↓ Sell10b5-1 | 2,858 | $70.08 | $200K | Direct | Nov 6, 2025 (2d) |
| Oct 8, 2024 | EXAS | ↓ Sell10b5-1 | 929 | $70.00 | $65K | Direct | Oct 9, 2024 (1d) |
| Sep 18, 2024 | EXAS | ↓ Sell10b5-1 | 929 | $70.00 | $65K | Direct | Sep 19, 2024 (1d) |
| May 1, 2024 | EXAS | ↓ Sell10b5-1 | 110 | $60.15 | $7K | Direct | May 2, 2024 (1d) |
| Apr 2, 2024 | EXAS | ↓ Sell10b5-1 | 924 | $79.43 | $73K | Direct | Apr 3, 2024 (1d) |
| Mar 1, 2024 | EXAS | ↓ Sell10b5-1 | 2,323 | $59.32 | $138K | Direct | Mar 4, 2024 (3d) |
| Feb 27, 2024 | EXAS | ↓ Sell10b5-1 | 2,027 | $56.89 | $115K | Direct | Feb 28, 2024 (1d) |
| Feb 22, 2024 | EXAS | ↓ Sell10b5-1 | 1,093 | $59.78 | $65K | Direct | Feb 23, 2024 (1d) |
| Feb 21, 2024 | EXAS | ↓ Sell10b5-1 | 895 | $61.50 | $55K | Direct | Feb 22, 2024 (1d) |
| Jan 2, 2024 | EXAS | ↓ Sell10b5-1 | 879 | $73.50 | $65K | Direct | Jan 4, 2024 (2d) |
| Aug 7, 2023 | EXAS | ↓ Sell10b5-1 | 1,350 | $85.04 | $115K | Direct | Aug 8, 2023 (1d) |
| Feb 28, 2023 | EXAS | ↓ Sell10b5-1 | 1,932 | $61.12 | $118K | Direct | Mar 1, 2023 (1d) |
| Feb 22, 2023 | EXAS | ↓ Sell10b5-1 | 838 | $62.72 | $53K | Direct | Feb 23, 2023 (1d) |
| Aug 5, 2022 | EXAS | ↓ Sell10b5-1 | 984 | $47.12 | $46K | Direct | Aug 8, 2022 (3d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other EXAS insiders
Open-market trades in the last 12 months
About Brian Baranick's insider trades
Brian Baranick is EVP, GM, Precision Oncology at Exact Sciences (EXAS). Since Aug 5, 2022, Brian has reported no open-market purchases and 14 sales worth $1.2M on SEC Form 4. There have been no open-market trades in the last 12 months.
14 sales (100% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include option exercises (12 filings), grants and awards (8 filings), shares withheld for taxes (5 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every EXAS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.